STAT March 24, 2025
It can fill in gaps left by government and major drug makers
Small, early-stage biotech startups are the heart of drug innovation in the U.S. Growing anti-competitive challenges threaten their work, but philanthropy may offer an avenue forward.
At the center of these challenges is the U.S. patent system and...